Table 1.
Variable Description and Summary Statistics.
| Variable | Description | Mean | SD |
|---|---|---|---|
| BLPAIN | Binary: 1 if the patient has baseline pain | 0.48 | - |
| BONEMET | Binary: 1 if the patient has bone metastases. | 0.88 | - |
| CAUCASIAN | Binary: 1 if the patient is Caucasian. | 0.81 | - |
| CHEMOGE3 | Binary: 1 if the patient has prior chemotherapy. | 0.29 | - |
| DPMEASBN | Binary: 1 if the patient has measurable disease. | 0.43 | - |
| TAX2PROG | Binary: 1 if the patient’s last Taxotere to progression is less than 6 months. | 0.89 | - |
| VISCMET | Binary: 1 if the patient has visceral metastases. | 0.23 | - |
| ECOG | Eastern Cooperative Oncology Group performance status of 0–2. | 0.32/0.61/0.071 | - |
| baseALP | Baseline Alkaline Phosphatase (U/L). | 221.18 | 223.96 |
| baseHB | Baseline Hemoglobin (g/DL). | 12.07 | 1.40 |
| basePSA | Baseline Prostate Specific Antigen (ng/mL). | 295.96 | 398.65 |
| BMI | Body Mass Index. | 28.01 | 4.61 |
| PSADT | Time (in days) for a patient’s PSA to double. | 5.02 | 4.90 |
| TIME_HORMONE | Time (in years) on hormone treatment. | 4.40 | 2.91 |
1
These three values represent the proportion of patients having performance status 0, 1 and 2.